Search hospitals
>
Missouri
>
Saint Louis
Mercy Hospital Saint Louis
Claim this profile
Saint Louis, Missouri 63141
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Brain Tumor
Conducts research for Breast cancer
511 reported clinical trials
5 medical researchers
Summary
Mercy Hospital Saint Louis is a medical facility located in Saint Louis, Missouri. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Brain Tumor, Breast cancer and other specialties. Mercy Hospital Saint Louis is involved with conducting 511 clinical trials across 682 conditions. There are 5 research doctors associated with this hospital, such as Jay W Carlson, Robin D. Hanson, Khaled Awad, and Dan-Arin Silasi, MD.
Area of expertise
Cancer
Mercy Hospital Saint Louis has run 81 trials for Cancer. Some of their research focus areas include:
Breast Cancer
Mercy Hospital Saint Louis has run 67 trials for Breast Cancer. Some of their research focus areas include:
Top PIs
Jay W Carlson
Mercy Hospital Saint Louis
7 years of reported clinical research
Robin D. Hanson
Mercy Hospital Saint Louis
8 years of reported clinical research
Khaled Awad
Mercy Hospital St. Louis
5 years of reported clinical research
Dan-Arin Silasi, MD
David C. Pratt Center
3 years of reported clinical research
Clinical Trials running at Mercy Hospital Saint Louis
Lung Cancer
Prostate Cancer
Kidney Cancer
Bladder Cancer
Ovarian Cancer
Breast Cancer
Cancer
Esophageal cancer
Bladder Carcinoma
Breast cancer
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting
2 awards
Phase 3
27 criteria
Treatment Timing
for Non-Small Cell Lung Cancer
This phase III trial compares standard therapy given after surgery (adjuvant) to standard therapy given before and after surgery (perioperative) in treating patients with stage II-IIIB non-small cell lung cancer (NSCLC) that can be removed by surgery (resectable). The usual approach for patients with resectable NSCLC is chemotherapy and/or immunotherapy before surgery, after surgery, or both before and after surgery. This study is being done to find out which approach is better at treating patients with lung cancer. Treatment will be administered according to the current standard of care at the time of enrollment. Chemotherapy options may include cisplatin, carboplatin, pemetrexed, gemcitabine, docetaxel, and vinorelbine at standard doses according to the treating physician. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of tumor cells. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Pemetrexed is in a class of medications called antifolate antineoplastic agents. It works by stopping cells from using folic acid to make deoxyribonucleic acid (DNA) and may kill tumor cells. Gemcitabine is a chemotherapy drug that blocks the cells from making DNA and may kill tumor cells. Docetaxel is in a class of medications called taxanes. It stops tumor cells from growing and dividing and may kill them. Other chemotherapy drugs, such as vinorelbine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading . Immunotherapy with monoclonal antibodies, such as nivolumab, pembrolizumab, and atezolizumab, may help the body's immune system attack the tumor, and may interfere with the ability of tumor cells to grow and spread. Starting treatment with chemotherapy and immunotherapy prior to surgery and continuing treatment after surgery may be a more effective treatment option than adjuvant therapy alone in patients with stage II-IIIB resectable NSCLC.
Recruiting
2 awards
Phase 3
4 criteria
Durvalumab
for Lung Cancer
This phase III trial compares durvalumab to the usual approach (patient observation) after surgery for the treatment of patients with early-stage non-small cell lung cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The usual approach for patients who are not in a study is to closely watch a patient's condition after surgery and to have regular visits with their doctor to watch for signs of the cancer coming back. Usually, patients do not receive further treatment unless the cancer returns. This study will help determine whether this different approach with durvalumab is better, the same, or worse than the usual approach of observation. Giving durvalumab may help patients live longer and prevent early-stage non-small cell lung cancer from coming back as compared to the usual approach.
Recruiting
2 awards
Phase 3
8 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Mercy Hospital Saint Louis?
Mercy Hospital Saint Louis is a medical facility located in Saint Louis, Missouri. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Brain Tumor, Breast cancer and other specialties. Mercy Hospital Saint Louis is involved with conducting 511 clinical trials across 682 conditions. There are 5 research doctors associated with this hospital, such as Jay W Carlson, Robin D. Hanson, Khaled Awad, and Dan-Arin Silasi, MD.
Where is Mercy Hospital Saint Louis located?
**Mercy Hospital St. Louis Location:** - Address: 615 S New Ballas Rd, St. Louis, MO. - Directions: Located at the intersection of I-270 and I-64/US 40. From I-64/US 40, take exit 29A for I-270 N, then exit 1B for I-270 S/I-64 E toward St. Louis. Continue on I-64 E, take exit 35 for New Ballas Rd, and turn left. The hospital is on the right.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Mercy Hospital Saint Louis, contact the Mercy Health Care Financial Assistance (HFA) department at (513) 956-3729 or visit their website. For inquiries, call Mercy Health customer service at 855-420-7900. To request a hard copy of the financial assistance application, call 608.741.7630 or 866.269.7115, visit the main reception or MercyCare Building (Monday-Friday, 8 am-4:30 pm), contact via MyChart, or email custserv@mhemail.org.
What insurance does Mercy Hospital Saint Louis accept?
Mercy Hospital Saint Louis accepts a wide range of health insurance types, including commercial, Medicare, and Medicaid, from numerous local and national carriers. It's crucial to verify coverage and restrictions with your insurance provider before scheduling visits. Additionally, Essence Healthcare's Medicare Advantage plans are now part of Mercy Hospital Saint Louis's provider network, enhancing access to high-quality care for members in the St. Louis area.
What awards or recognition has Mercy Hospital Saint Louis received?
Mercy Hospital Saint Louis, located in Saint Louis, Missouri, was awarded the Cutting Edge Award by the St. Louis Business Journal in 2019 for innovative centralization of research activities. It has also been recognized as one of the top five large U.S. health systems for four consecutive years by IBM Watson Health.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.